Delivery Order SPE2DR25D2205-SPE2DR26F1M61
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,498.10 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction under AmerisourceBergen's broader federal medical supply portfolio and reflects...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,163.54 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This firm fixed price contract, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made on a non-set-aside, competitive basis and will be performed at...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $1,023.62 firm fixed-price delivery order for Dexcom G7 sensors, with an ultimate completion date of September 5, 2025. This competitively awarded contract, issued on September 4, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,287.63 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on September 15, 2025, with completion expected by September 16, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from the contractor's...
- The Defense Logistics Agency awarded a $2,280.80 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency has awarded a delivery order valued at $1,694.39 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. This firm fixed price, competitively awarded contract was issued on September 22, 2025, with an ultimate completion date of September 23, 2025. The delivery will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,891.14 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. The contract, which became effective on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order under its existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,007.81 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on June 25, 2025, with completion scheduled for June 26, 2025. This firm fixed price, non-set-aside delivery order represents a continuation of federal medical supply procurement through the company's existing contract vehicle with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical and medical device distributor...
- The Defense Logistics Agency awarded a $1,248 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with a completion date of December 2, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which runs through December 2026. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $1,051.18 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Dexcom G7 sensors, continuous glucose monitoring devices used for diabetes management. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle valued through December 2026. The...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F1M61Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,660.42 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors, with an ultimate completion date of December 8, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies critical medical commodities to support military and federal healthcare systems. The Dexcom G7 sensors being procured under this delivery order represent specialized diabetes management devices used across the Defense Health Agency's medical supply chain. This award reflects AmerisourceBergen's established capability to deliver medical devices and pharmaceutical products to federal customers through competitive procurement processes, with no set-aside designation applied.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/4/25 |